Physicians need to share info
Physicians prescribing new medications often fail to communicate potential side effects, dosing instructions and the name of the drug to patients, a study by University of California-Los Angeles researchers finds. The study, published in the Sept. 25 Archives of Internal Medicine, reports that 62% of necessary information was conveyed based on a survey of patients from two Sacramento healthcare systems. "More research is needed to investigate how much time physicians spend educating patients about new medications and whether better communication is associated with more appropriate medication use and health outcomes," the article says...
You may also be interested in...
US FDA looks to post-marketing studies to address elements of the NDA that were not central to its initial swift approval as the first COVID-19 therapy, including pediatric use and the interaction of hepatotoxicity and dose duration.
But advisory committee members caution against including pediatric population in COVID-19 vaccine trials, and one member expresses concern that Pfizer is testing those as young as 12 years of age. Agency is in discussions with product sponsors about enrollment of adolescents.
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.